☰

Xiao-Feng Zhou, Ph.D. - Publications

Affiliations: 
2001 The University of Toledo 
Area:
Molecular Biology, Pharmacology
Tree Info Grants Similar researchers PubMed Report error

8 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Park NJ, Zhou X, Yu T, Brinkman BM, Zimmermann BG, Palanisamy V, Wong DT. Characterization of salivary RNA by cDNA library analysis. Archives of Oral Biology. 52: 30-5. PMID 17052683 DOI: 10.1016/J.Archoralbio.2006.08.014  0.301
2006 Omwancha J, Zhou XF, Chen SY, Baslan T, Fisher CJ, Zheng Z, Cai C, Shemshedini L. Makorin RING finger protein 1 (MKRN1) has negative and positive effects on RNA polymerase II-dependent transcription. Endocrine. 29: 363-73. PMID 16785614 DOI: 10.1385/Endo:29:2:363  0.571
2005 Kim Y, McBride J, Zhang R, Zhou X, Wong DT. p12(CDK2-AP1) mediates DNA damage responses induced by cisplatin. Oncogene. 24: 407-18. PMID 15543230 DOI: 10.1038/Sj.Onc.1208222  0.362
2001 Shenk JL, Fisher CJ, Chen SY, Zhou XF, Tillman K, Shemshedini L. p53 represses androgen-induced transactivation of prostate-specific antigen by disrupting hAR amino- to carboxyl-terminal interaction. The Journal of Biological Chemistry. 276: 38472-9. PMID 11504717 DOI: 10.1074/Jbc.M103652200  0.718
2000 Bubulya A, Zhou XF, Shen XQ, Fisher CJ, Shemshedini L. c-Jun targets amino terminus of androgen receptor in regulating androgen-responsive transcription. Endocrine. 13: 55-62. PMID 11051047 DOI: 10.1385/Endo:13:1:55  0.743
1999 Shen XQ, Bubulya A, Zhou XF, Khazak V, Golemis EA, Shemshedini L. Ligand-free RAR can interact with the RNA polymerase II subunit hsRPB7 and repress transcription. Endocrine. 10: 281-9. PMID 10484292 DOI: 10.1007/Bf02738627  0.725
1999 Zhou XF, Shen XQ, Shemshedini L. Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization. Molecular Endocrinology (Baltimore, Md.). 13: 276-85. PMID 9973257 DOI: 10.1210/Mend.13.2.0237  0.744
1998 Wise SC, Burmeister LA, Zhou XF, Bubulya A, Oberfield JL, Birrer MJ, Shemshedini L. Identification of domains of c-Jun mediating androgen receptor transactivation. Oncogene. 16: 2001-9. PMID 9591784 DOI: 10.1038/Sj.Onc.1201697  0.728
Show low-probability matches.